These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6287380)

  • 21. [Activation of latent infections caused by the Epstein-Barr virus in systemic lupus erythematosus].
    Anan'eva LP; Alekberova ZS; Nasonova VA; Stepina VN
    Revmatologiia (Mosk); 1986; (1):39-43. PubMed ID: 3012745
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of antibodies to EB virus in infectious mononucleosis patients.
    Sobéslavský O; Kouba K; Lasovská J; Pokorný J; Kucharska Z; Vojtĕchovský K; Seeman J; Syrcek L
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):370-6. PubMed ID: 4342924
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of peripheral white blood cell pattern in infectious mononucleosis].
    Janeczko J
    Wiad Lek; 1979 Sep; 32(18):1301-4. PubMed ID: 228501
    [No Abstract]   [Full Text] [Related]  

  • 24. Epstein-Barr virus and its antigens.
    Raab-Traub N; Pagano JS
    Immunol Ser; 1989; 43():477-98. PubMed ID: 2562309
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition.
    Lai PK; Alpers MP; MacKay-Scollay EM
    Infect Immun; 1977 Jul; 17(1):28-35. PubMed ID: 195902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epstein-Barr virus infection in children: study of infectious mononucleosis without heterophil antibodies].
    Baccard C; François P; Bost M; Bachelot C; Decret M; Beaudoing A; Seigneurin JM
    Ann Pediatr (Paris); 1983 Jun; 30(6):416-21. PubMed ID: 6309061
    [No Abstract]   [Full Text] [Related]  

  • 27. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
    Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
    Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic studies in infectious mononucleosis in children].
    Timár L; Koller M; Szigeti R; Budai J; Kuti D
    Orv Hetil; 1982 Oct; 123(44):2709-12. PubMed ID: 7145432
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the incidence of infectious mononucleosis and the presence of Epstein-Barr virus antibodies in the cases of pediatric general medicine service].
    Zappulla F; Re MC; Mazzanti L; Zanelli MG; Sandri S; Baldassarri B; Alonge C; Ragni I; Parisini O; Lucchi A
    Minerva Pediatr; 1984 Oct; 36(19):923-6. PubMed ID: 6099462
    [No Abstract]   [Full Text] [Related]  

  • 31. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus and human lymphoproliferative disorders.
    Schnipper LE
    Prog Hematol; 1981; 12():275-97. PubMed ID: 6280236
    [No Abstract]   [Full Text] [Related]  

  • 33. Infectious mononucleosis: immunotherapy with EBV-specific transfer factor?
    Jones JF; Pizza G; DeVinci CD
    J Exp Pathol; 1987; 3(4):399-406. PubMed ID: 2842474
    [No Abstract]   [Full Text] [Related]  

  • 34. A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition.
    Timár L; Budai J; Koller M
    Infection; 1982; 10(3):139-43. PubMed ID: 6286500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious mononucleosis and Epstein-Barr virus in Japan. II. Cellular aspects.
    Takiuchi Y; Tatsumi E; Nasu K; Shirakawa S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):864-71. PubMed ID: 6277135
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 37. Sudden hearing loss following infectious mononucleosis: possible effect of altered immunoregulation.
    Williams LL; Lowery HW; Glaser R
    Pediatrics; 1985 Jun; 75(6):1020-7. PubMed ID: 2987786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor.
    Szigeti R; Luka J; Klein G
    Cell Immunol; 1981 Mar; 58(2):269-76. PubMed ID: 6260386
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of a reagent for the diagnosis of Epstein-Barr virus infection].
    de Ory F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):506-7. PubMed ID: 9011214
    [No Abstract]   [Full Text] [Related]  

  • 40. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.